Table 1 Participants’ characteristics of UK Biobank

From: Plasma proteomic profiles predict individual future health risk

Participants characteristics

All participants (N = 52,006)

Female (N = 28,056)

Male (N = 23,950)

Demographic

Age

58 [50–64]

58 [50–63]

59 [50–64]

Ethnicity (white)

48,517 (93.7%)

26,204 (93.8%)

22,313 (93.7%)

Townsend deprivation index

−2.1 [−3.6 to 0.8]

−2.1 [−3.6 to 0.7]

−2.1 [−3.6 to 0.9]

Education, years

11 [10–15]

11 [10–15]

11 [10–15]

Lifestyle

Current smoker

5481 (10.6%)

2492 (8.9%)

2989 (12.5%)

Frequent alcohol intake

35,615 (68.6%)

17,248 (61.6%)

18,367 (76.9%)

Regular activity

39,548 (78.0%)

21,094 (77.2%)

18,454 (78.9%)

Physical measures

Body mass index

26.8 [24.2–29.9]

26.2 [23.5–29.8]

27.3 [25.0–30.0]

Basal metabolic rate, kj

6360 [5489–7581]

5552 [5184–6000]

7657 [7037–8355]

Systolic blood pressure, mmHg

138 [126–152]

135 [122–150]

141 [130–154]

Disease and medication history

History of diabetes

2948 (5.7%)

1098 (3.9%)

1850 (7.7%)

History of hypertension

14,605 (28.1%)

6745 (24.0%)

7860 (32.8%)

Cholesterol medications

9678 (18.9%)

3747 (13.5%)

5931 (25.2%)

Family disease history

Parents’ history of diabetes (single)

7565 (16.7%)

4293 (17.2%)

3272 (16.1%)

Parents’ history of diabetes (both)

603 (1.3%)

319 (1.3%)

284 (1.4%)

Parents’ history of dementia (single)

5421 (12.0%)

3132 (12.6%)

2289 (11.2%)

Parents’ history of dementia (both)

222 (0.5%)

121 (0.5%)

101 (0.5%)

Serum

HDL cholesterol, mmol/L

1.4 [1.2–1.7]

1.5 [1.3–1.8]

1.2 [1.1–1.4]

Triglycerides, mmol/L

1.5 [1.0–2.1]

1.3 [1.0–1.9]

1.7 [1.2–2.4]

Glucose, mmol/L

4.9 [4.6–5.3]

4.9 [4.6–5.3]

5.0 [4.6–5.4]

HbA1c, mmol/mol

35.3 [32.9–38.1]

35.3 [32.9–37.9]

35.4 [32.8–38.3]

IGF-1, nmol/L

21.2 [17.4–24.7]

20.6 [16.8–24.4]

21.7 [18.1–25.1]

Alanine aminotransferase, U/L

20.0 [15.3–27.1]

17.5 [13.9–22.8]

23.4 [18.2–31.4]

Albumin, g/L

45.1 [43.4–46.9]

44.9 [43.2–46.6]

45.4 [43.7–47.2]

Creatinine, umol/L

70.7 [61.4–81.4]

63.2 [57.0–70.5]

80.2 [72.6–88.9]

Leukocyte count, 109 cells/L

6.6 [5.6–7.9]

6.6 [5.6–7.8]

6.7 [5.6–7.9]

Erythrocyte count, 1012 cells/L

4.5 [4.2–4.8]

4.3 [4.1–4.5]

4.7 [4.5–5.0]

Platelet count, 109 cells/L

248.0 [213.0–287.0]

261.0 [225.2–300.0]

233.2 [201.0–269.0]

  1. Continuous data are described as median [interquartile range], and categorical variables are presented as numbers (percentages). See Supplementary Data 2 for full clinical predictors and detailed notations.
  2. IGF-1 insulin-like growth factor 1, HDL high-density lipoprotein.